China Market Intelligence

June 14th, 2017
By David Solomon

Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies in China.

Congressional Legislative Tracker

The USCBC Government Affairs team continuously monitors China-related bills and broader legislative trends spanning a variety of issue areas, including trade and investment, national security, telecommunications, and human rights.

LEARN MORE